Navigation Links
Korean Stem Cells Allow Artist to Paint Again

ROCKVILLE, Md., March 31 /PRNewswire/ -- John Lawson Cullison, Jr., an artist known for his work in the genre of visionary realism or "new age art," lost his ability to paint due to the effects of arthritis. This incurable condition is due to the degeneration in cartilage tissue and symptoms include: pain, tenderness in the joints, stiffness, loss of flexibility, bone spurs and severe swelling. Pain management and joint replacement surgery are the typical means to treating this condition. Cullison was taking prescription pain medication for over 15 years when he finally decided to seek treatment that was unavailable in the United States.

RNL Bio, a South Korean adult stem cell therapy company, developed a method to take one's own stem cells from fat tissue and make identical copies that have no genetic modifications and no cancer risks so that high doses of stem cells can be administered back into the body. The stem cells that come from fat tissue can easily form new tissues. Given that characteristic, the stem cells have the capacity to treat any tissue degenerative disease which includes, Parkinson's Disease, Spinal Cord Injury, Renal Failure, among many. When Cullison heard of the treatment, he sent a small fat sample to RNL Bio, where the cells would be manufactured under the strictest safety and quality conditions.

February 2009, Cullison made the trip to Seoul, South Korea where he was escorted by RNL staff to The Sunrise Regenerative Medical Center, their stem cell hospital in Yanji, China to receive intravenous and local injections of his own stem cells. When asked about his decision to seek this new and developing treatment, he said, "I had more faith in that [the fact that RNL was using my own stem cells] because I knew that I would be receiving the material that genetically was supposed to be in me.".

A week after his injection, Cullison began to see small improvements and after two weeks, he no longer needed his cane to walk. He noticed that his joints were feeling better, his vision was improving to the point that his glasses were outdated, his eyes were getting bluer (eye pigmentation is often an indicator of good health) and his legs were getting stronger. "This is major improvement and it's only been 2 weeks! Six months from now, I'll be doing back-flips!" Only three weeks post treatment, Cullison reported that he was no longer taking any medication and back to painting his pictures.

President and CEO of RNL Bio, Dr. Jeong Chan Ra said, "John Cullison arrived in Korea as an old man. He is returning to his home, an adolescent". After witnessing the remarkable improvement of Cullison as well as patients being treated with RNL stem cells, Ra is committed to making RNL stem cell therapy an accessible and affordable treatment, globally.

About RNL Bio

RNL Bio is a premier biotechnology company focused on the research and development of adult derived stem cell therapies. RNL has two therapies in Phase II clinical trials for Buerger's Disease as well as Osteoarthritis. RNL is a publically traded company on the Korean Stock Exchange (Code 003190) and plans to expand its operations throughout the world. For questions regarding the press conference or receiving stem cell therapy, please contact, Jin Han Hong, at

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chronic gastrointestinal symptoms in Korean population
2. Cynosures Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval
3. CHRI Gets Great Progress on the Korean Herb Market
4. China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System
5. Eye Cells Believed to Be Retinal Stem Cells Are Misidentified
6. After heart attack, bone marrow stem cells increase blood flow within heart
7. Scientists Capture HIV Transfer Among T-Cells on Video
8. Study Links Sugar Production in Yeast Cells to Longevity
9. Physician Group Opposes FDA's Position on Adult Stem Cells
10. TV crime drama compound highlights immune cells misdeeds
11. Biotech company cofounded by BIDMC scientists targets natural killer T-cells
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Physicians’ Education Resource®, LLC ... today announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will be ... and treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with powerful ...
(Date:12/1/2015)... ... 2015 , ... Growth in medical payments per workers’ compensation claim in Louisiana ... and nonhospital care, according to a recent study by the Workers Compensation Research Institute ... found medical payments per claim with more than seven days of lost time continued ...
(Date:12/1/2015)... Illinois (PRWEB) , ... December 01, 2015 , ... ... and share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ ... Society of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. ... results enhancements at the Radiological Society of North America (RSNA) 2015 annual meeting ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... solutions for the care management and population health arenas, is pleased to announce ... and cost containment services, has successfully implemented the ACUITY Complete Care™ Management to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Germany , December 1, 2015 /PRNewswire/ ... leading global manufacturer of eye and gaze tracking solutions, ... SMI remote eye trackers as a component of its ... concussions, eye sight, and medical and performance issues in ... part of SMI,s mass-market-ready eye tracking platform, which is ...
(Date:12/1/2015)... 1, 2015 --> ... van Leeuwenhoek Hospital (NKI-AVL), among the world,s largest ... Leksell Gamma Knife® Icon™, the company,s latest generation ... --> --> With the ... treatments, Leksell Gamma Knife Icon offers greatly enhanced ...
(Date:12/1/2015)... Dec. 01, 2015 ... "Drug Delivery Technology Market 2015 - Forecast ... --> ) has announced the addition ... - Forecast to 2020" report to their ... ) has announced the addition of the ...
Breaking Medicine Technology: